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Homeostatic scaling is a non-Hebbian form of neural
plasticity that maintains neuronal excitability and
informational content of synaptic arrays in the face
of changes of network activity. Here, we demonstrate
that homeostatic scaling is dependent on group I
metabotropic glutamate receptor activation that is
mediated by the immediate early gene Homer1a.
Homer1a is transiently upregulated during increases
in network activity and evokes agonist-independent
signaling of group I mGluRs that scales down the
expression of synaptic AMPA receptors. Homer1a
effects are dynamic and play a role in the induction
of scaling. Similar to mGluR-LTD, Homer1a-depen-
dent scaling involves a reduction of tyrosine phos-
phorylation of GluA2 (GluR2), but is distinct in that it
exploits a unique signaling property of group ImGluR
to confer cell-wide, agonist-independent activation
of the receptor. These studies reveal an elegant
interplay of mechanisms that underlie Hebbian and
non-Hebbian plasticity.
INTRODUCTION
Neurons maintain basic properties of excitability despite
changes in synaptic input that naturally occur either because
of Hebbian changes in synaptic strength or activity of the
network of neurons that drive their firing (Turrigiano, 2008).
One homeostatic adaptation involves a cell-wide increase or
decrease of postsynaptic AMPAR at excitatory synapses. This
process is thought to occur in a manner that maintains the rela-
tive strengths of synapses by effectively scaling all synapses by
the same multiplicative factor (Turrigiano and Nelson, 2000).
Homeostatic scaling can be modeled in primary neuronal
cultures wherein the strength of synapses is scaled up by dimin-
ished network activity, or scaled down by increased network
activity. Recent studies have provided insights into themolecular
basis of homeostatic scaling. One mechanism involves the1128 Neuron 68, 1128–1142, December 22, 2010 ª2010 Elsevier Inccellular immediate early gene (IEG) termed Arc (also termed
Arg3.1). Consistent with its regulation as an IEG in vivo (Lyford
et al., 1995), addition of bicuculline to cultures increases network
activity and increases Arc protein expression (Shepherd et al.,
2006). Arc is a cytosolic protein that interacts with endocytic
proteins including endophilin2/3 and dynamin to enhance the
rate of endocytosis of AMPAR (Chowdhury et al., 2006), and
consequently its upregulation reduces synaptic AMPAR (Shep-
herd et al., 2006). This cell wide, postsynaptic mechanism is
tuned to the physiological range of neuronal activities.
Studies of Arc also provide insight into how neurons can inte-
grate Hebbian plasticity with homeostatic scaling. Acute activa-
tion of group I mGluRs on hippocampal or cortical neurons
results in rapid and sustained depression of synaptic transmis-
sion (mGluR-LTD) by a mechanism that requires de novo trans-
lation of mRNAs (Snyder et al., 2001), including Arc (Park et al.,
2008; Waung et al., 2008), and is mediated by accelerated endo-
cytosis of surface AMPAR. De novo translation of Arc required
for mGluR-LTD is dependent on elongation factor 2 kinase
(eEF2K) activation, which can be regulated locally by synaptic
activity. eEF2K is not required for Arc translation in response to
growth factors or for delayed responses to mGluR activation,
and homeostatic scaling is preserved in the eEF2K knonkcout
(KO). Thus, differences in the translational regulation of Arc
underlie its conditional contributions to homeostatic scaling
versus mGluR-LTD. These observations highlight mechanistic
similarities and differences between homeostatic scaling and
mGluR-LTD.
In the present study, we report that group I mGluRs signaling
plays an essential role in homeostatic scaling. Themechanism of
activation of mGluR in homeostatic scaling is distinctly different
than in mGluR-LTD, wherein Hebbian effects are mediated by
local activation of the receptor by synaptically released gluta-
mate. In homeostatic scaling, group I mGluRs activation is not
due to glutamate acting on the receptor, but rather is due to
the induction of the IEG Homer1a in the postsynaptic neuron,
which creates a cell wide, agonist-independent activation of
mGluR. Homer1a binds a consensus proline rich sequence
(PPXXF) present in the C terminus of group I metabotropic gluta-
mate receptors (mGluR), and disrupts the crosslinking action of
constitutively expressed forms of Homer (Brakeman et al., 1997;.
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the mGluR in the absence of glutamate (Ango et al., 2001), and
this mechanism appears central to the action of Homer1a in
homeostatic scaling. Studies further reveal Homer1a-dependent
scaling is not dependent onArc, but rather is linked to a reduction
of the tyrosine phosphorylation of the AMPAR subunit GluA2
(GluR2). Changes in tyrosine phosphorylation of GluA2 have
previously been implicated in insulin-dependent LTD (Ahmadian
et al., 2004) and mGluR-LTD (Gladding et al., 2009). The involve-
ment of regulated tyrosine phosphorylation of GluA2 in homeo-
static scaling demonstrates a convergent molecular mechanism
that may be differentially evoked either locally or cell-wide to
produce Hebbian or non-Hebbian plasticity.
RESULTS
Agonist-Independent Activity of Group I mGluRs
Is Required for Homeostatic Scaling
We examined the hypothesis that group I mGluR activity contrib-
utes to homeostatic scaling using antagonists of mGluR1 and
mGluR5. The pharmacology of group I mGluR antagonists is
notable in that it includes agents that competitively inhibit the
glutamate binding pocket in the N terminus (O’Hara et al.,
1993), as well as agents that noncompetitively bind within the
transmembrane domain (Pagano et al., 2000). Noncompetitive
agents can act as inverse agonists if they block agonist-indepen-
dent activity, or as neutral antagonists if they do not block
agonist-independent activity (Milligan, 2003). Days in vitro (DIV)
14 cortical neurons in culture were chronically treated with bicu-
culline (bic, 40 mM) in the presence or absence of group I mGluR
antagonists, and scaling of AMPARs was monitored by surface
biotinylation and immunohistochemistry (IHC). As expected,
chronic bicuculline treatment reduced the levels of GluA1
(GluR1) and GluA2/3 (GluR2/3) on the cell surface. Inhibition of
mGluR1 and mGluR5 with inverse agonists Bay 36-7620 (Bay,
10 mM) and 2-methyl-6-(phenylethynyl)-pyridine (MPEP, 5 mM)
prevented the effect of bicuculline to reduce surface GluA1
and GluA2/3 (Figures 1A and 1B). Figure 1A illustrates a repre-
sentative western blot at a single exposure, while quantitative
data (Figure 1B) were obtained from additional exposures to
assure signals were in the linear range. (The same approach is
used for western data in all figures.) A similar effect was
observed with the structurally different mGluR1 inverse agonist,
LY367385 (LY, 100 mM) (Pula et al., 2004), together with MPEP
(Figures 1A and 1B). Single treatment with Bay, LY, or MPEP
did not prevent bicuculline-induced downregulation of surface
AMPAR (data not shown), indicating that inhibition of both
mGluR1 and mGluR5 is required. Competitive or neutral antago-
nists of group I mGluR did not block bicuculline-induced down-
regulation of GluA1 and GluA2/3 as shown by inhibition of
mGluR1 with the neutral antagonist CPCCOEt (CP, 100 mM),
and mGluR5 with the competitive antagonist (S)-MCPG
(500 mM) (Figures 1A and 1B). This combination was verified to
block the effect of group I mGluR signaling on ERK phosphory-
lation to a similar extent as Bay and MPEP (Figures S1A and
S1B available online). CP (100 mM) combined with higher dose
(S)-MCPG (2.5 mM) also failed to block bicuculline-induced
downregulation of GluA1 and GluA2/3 (Figures S1C and S1D).NeBay and MPEP, but not CP and MCPG, prevented bicuculline-
evoked downregulation of surface GluA1 and GluA2 staining
(Figures 1C and 1D). Competitive blockade of group I and
group II mGluRs with the LY341495 (100 mM) (Kingston et al.,
1998) also failed to prevent bicuculline-induced downregulation
of surface GluA1 and GluA2/3 (Figures S1C and S1D).
The failure of CP and MCPG or LY341495 to block scaling to
bicuculline suggests that mGluR activation is not due to gluta-
mate released at synapses or glutamate that might accumulate
in the medium. To further examine this issue, we added gluta-
mate-pyruvate transaminase (GPT) to the medium during
chronic bicuculline treatment at a concentration reported to
prevent local accumulation of glutamate at synapses (Matthews
et al., 2000; Pula et al., 2004). The Kd of GPT for glutamate
is 8 mM and this is close to the measured level of glutamate
in the medium of our cultures (7 mM). GPT did not alter the
effect of chronic bicuculline to downregulate surface GluA1
and GluA2/3 (Figures S1E and S1F).
Effects of group I mGluR antagonists on bicuculline-evoked
scaling were examined in parallel using electrophysiological
recordings. Chronic treatment with Bay and MPEP produced
an increase in the miniature excitatory postsynaptic current
(mEPSC) amplitudes (control 20.9 ± 1.1 pA; n = 24 cells versus
Bay/MPEP 26.7 ± 1.9 pA; n = 21 cells; #p < 0.05), and blocked
the effect of bicuculline (bic 14.1 ± 0.2 pA; n = 28 cells versus
bic/Bay/MPEP 25.7 ± 2.0 pA; n = 18 cells) (Figures 1E and 1F).
By contrast, chronic CP and MCPG did not block the effect of
bicuculline (amp: 13.5 ± 0.4 pA, **p < 0.01; frequency: 22.8 ±
2.6 Hz, n = 22 cells), and did not produce an increase in the basal
mEPSC amplitude (21.8 ± 0.9 pA, n = 11 cells, Figures 1E and 1F)
or frequency (22.0 ± 2.8 Hz, n = 11 cells). The cumulative histo-
gram of mEPSCs indicates that Bay 36-7620 and MPEP
produced a multiplicative increase of amplitudes, suggesting
the antagonists produce a scaling up of relative synaptic weights
(Turrigiano and Nelson, 2000). Chronic Bay and MPEP also
increased the frequency of mEPSCs (control 23.4 ± 2.6 Hz;
n = 24 cells versus Bay/MPEP 36.4 ± 4.4 Hz; n = 21 cells; #p <
0.05). This is consistent with either a presynaptic action of group
I mGluRs or the possibility that Bay and MPEP convert silent
synapses to active synapses.
Homer1a Scales AMPA Receptors and Is Dependent
on Group I mGluRs
To assess if Homer1a can activate group I mGluRs in cortical
neurons to downregulate surface AMPARs, we expressed
Homer1a transgene by Sindbis virus infection for 24 hr, and
assayed surface AMPARs by biotinylation and IHC. We
compared effects of Homer1a with that of Arc (Shepherd et al.,
2006). Neurons were treated with tetrodotoxin (TTX, 1 mM) to
reduce native expression of Homer1a and Arc, and thereby
isolate the action of the transgenes. Surface GluA1 and GluA2/3
were reduced in neurons that expressed Homer1a or Arc,
compared to GFP (Figures 2A and 2B). Notably, Bay and MPEP
blocked the action of Homer1a to downregulate AMPARs, but
did not block the effect of Arc (Figures 2A and 2B). IHC confirmed
that Homer1a or Arc expression reduces surface GluA1 and
GluA2 expression. Bay and MPEP blocked the action of
Homer1a, but not the action of Arc (Figures 2C–2F), suggestinguron 68, 1128–1142, December 22, 2010 ª2010 Elsevier Inc. 1129
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Figure 1. Group I mGluR Inverse Agonists Block Homeostatic Scaling of AMPARs
(A and B) Western blot and quantification of DIV14 cortical neurons treated with bicuculline (40 mM, 48 hr) and assayed for surface expression of AMPARs.
Bicuculline reduced surface GluA1 and GluA2/3. Coapplication of inverse agonists of mGluR1 (Bay 36-7620; 10 mM) and mGluR5 (MPEP, 5 mM) or LY367385
(100 mM) together with MPEP blocked bicuculline effect, whereas the neutral antagonists CPCCOEt (100 mM) and (S)-MCPG (500 mM) did not. n = 5–12 for
each group; *p < 0.05, ***p < 0.001 versus no bicuculline-treated control; #p < 0.05 versus no treatment control; n.s.: no significance; Bic: bicuculline; Bay:
Bay 36-7620; LY: LY367385; CP: CPCCOEt in this and all subsequent figures.
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Neuron
Homer1a and Homeostatic Scalingthat Homer1a acts upstream of group I mGluR while Arc acts
downstream.
Generation of Homer1a-Specific Knockout Mice
We generated gene-targeted mice carrying a modified Homer1
allele that selectively prevents the expression of immediate-
early gene forms of Homer1 including Homer1a and Ania3
(termed Homer1a KO; Figures S2A–S2D and Experimental
Procedures). Homer1b/c, 2, and 3 protein expression is not
changed in Homer1a KOs when compared with wild-type (WT)
(Figure S2E). Similarly, expression of glutamate receptors
mGluR1, mGluR5, GluA1, GluA2/3, and NR1 is not altered in
Homer1a KO brains (Figure S2E). Homer1a KO mice are fertile,
born at Mendelian frequency, and do not display obvious
anatomical abnormalities. Maximal electroconvulsive seizure
(MECS) induced Homer1a protein in WT mice, but not in Hom-
er1a KO mice, and MECS did not alter Homer1b/c expression
in either WT or Homer1a KO mice (Figure S2F).
Synaptic AMPARs Are Upregulated in Homer 1a KO
Neurons in Culture
IHC and surface biotinylation assays revealed GluA1 and GluA2
are elevated on the surface of Homer1a KO neurons prepared
from E18 cortex and cultured 14 DIV (Figures 3A–3D), whereas
total levels of GluA1 and GluA2/3 were not different from WT
neurons (Figures 3C and 3D). Surface mGluR5 is also signifi-
cantly increased on Homer 1a KO neurons (Figures 3C and
3D). Whole cell recordings of pyramidal neurons confirm an
increase in the average amplitude of mEPSCs in Homer1a KO
neurons (28.9 ± 1.3 pA; n = 33 cells; Figure 3E) compared
to WT neurons (20.9 ± 1.1 pA; n = 24 cells; ***p < 0.001), and
indicate the increase is distributed over the entire range of
recorded events consistent with scaling (Figure 3E). There was
no difference in the frequency between WT (23.4 ± 2.6 Hz; n =
24 cells) and Homer1a KO neurons (25.3 ± 2.9 Hz; n = 33 cells;
Figure 3E).
Homer 1a Transgene Reverses the Increase of AMPA
Receptors in Homer1a KO Neurons
We asked whether Homer1a expression would rescue the
phenotype of Homer1a KO neurons of increased synaptic
AMPAR. To mimic the dynamic increase of Homer1a that occurs
with IEG expression, we used Sindbis virus infection for 14–18 hr.
We noted that mEPSCs recorded from Sindbis virus-expressing
neurons were generally less than noninfected neurons of
the same DIV, perhaps due to effect of Sindbis to usurp host
cell protein translation (Xiong et al., 1989). Accordingly, we
compared Sindbis virus infected neurons expressing Homer1a(C and D) Immunocytochemistry and quantification of DIV14 cortical neurons trea
and GluA2. Bicuculline treatment downregulated surface GluA1 and GluA2. Coa
prevented the bicuculline scaling. Coapplication of neutral antagonists CP/MCPG
sents 30 mm and 5 mm in magnified dendrites). n = 24; ***p < 0.001 versus no bic
(E and F) Representative whole-cell recording traces and cumulative probabil
(n = 24 cells), Bic- (n = 28 cells), Bay/MPEP- (n = 21 cells), Bic/Bay/MPEP- (n =
neurons. Inset: bar graphs represent the mEPSC mean amplitude or frequency o
inverse agonists, but not neutral antagonists. Neurons treated with Bay/MPEP s
***p < 0.001 versus no bicuculline-treated control; #p < 0.05 versus no treatment
correction. Scale = 60 pA, 0.1 s.
Neversus GFP. mEPSC amplitudes recorded from Homer1a
KO neurons expressing Homer1a transgene (13.7 ± 0.5 pA;
n = 10 cells; *p < 0.05; Figures 4A and 4B) were significantly
smaller than those recorded from neurons expressing only
GFP (18.4 ± 1.6 pA; n = 13 cells). The shift to lowermEPSC ampli-
tudes due to Homer1a expression was multiplicative. There was
no difference in the frequency of mEPSCs between Homer1a
(13.8 ± 1.7 Hz; n = 10 cells) and GFP expression (18.6 ±
3.0 Hz; n = 13 cells; Figure 4C). Biotinylation assays confirmed
that surface expression of GluA1, GluA2/3, and mGluR5 were
significantly reduced in Homer1a KO neurons that expressed
Homer1a transgene compared with GFP, whereas total levels
of AMPARs and mGluR5 were unchanged (Figures 4D and 4E).
Consistent with the action of Homer1a to compete with
Homer1c, Homer1a expression reduced the coimmunoprecipi-
tation (co-IP) of mGluR5 with Homer1c compared to GFP-ex-
pressing neurons (Figure 4F).
Homer1a Contributes to Homeostatic Scaling
of AMPA Receptors
We monitored Homer1a mRNA and protein in DIV 14 cortical
neurons treated with TTX or bicuculline for 3 hr, 6 hr, 12 hr,
24 hr, and 48 hr (Figure 5A). Bicuculline produced a time-depen-
dent increase that was maximum at 6hrs for mRNA and 12 hr for
protein (each 8-fold), and returned to basal levels at 48 hr. By
contrast, TTX treatment reduced Homer1a mRNA 5-fold by
24 hr and protein by 4-fold at 48 hr.
To assess how Homer1a KO affects homeostatic scaling, we
examined the surface levels of AMPARs after chronic TTX or
bicuculline treatment. Biotinylation and IHC assays revealed an
absence of homeostatic adaptations of GluA2/3 in Homer1a KO
neurons (Figures 5B–5E). Homeostatic adaptations of GluA1
were significantly reduced in Homer 1a KO neurons, but not
as strikingly disrupted as GluA2. Homeostatic adaptations
of mGluR5 were not significantly different in Homer1a KO
neurons.
Disruption of homeostatic scaling in Homer1a KO neurons
was also evident in mEPSCs recordings (Figures 5F and 5G).
In contrast to WT neurons where TTX resulted in an increase of
mEPSC (WT-control 20.9 ± 1.1 pA; n = 24 cells; TTX-treated
30.1 ± 2.2 pA; n = 15 cells, ***p < 0.001), mEPSC amplitudes of
TTX-treated Homer1a KO neurons (31.4 ± 2.6 pA; n = 20 cells)
were not significantly greater than untreated Homer1a KO
neurons (28.9 ± 1.3 pA; n = 33 cells) (Figure 5G). Similarly,
chronic bicuculline treatment reduced mEPSC amplitudes in
WT neurons (14.1 ± 0.2 pA; n = 28 cells; ***p < 0.001), but did
not produce a significant decrease in mEPSC amplitudes in
Homer1a KO neurons (27.2 ± 1.9 pA; n = 35 cells) compared toted with bicuculline (40 mM, 48 hr) and assayed for surface expression of GluA1
pplication of Bay/MPEP increased surface GluA1 and GluA2 expression, and
did not alter surface GluA1 and GluA2 or bicuculline scaling (scale bar repre-
uculline-treated control; ###p < 0.001 versus no treatment control.
ity distribution of mEPSC amplitude or frequency from all events in control
18 cells), CP/MCPG- (n = 11 cells), and Bic/CP/MCPG- (n = 22 cells) treated
f each population. The effect of bic on mEPSC was blocked by group I mGluR
howed an increase in both amplitude and frequency of mEPSCs. **p < 0.01,
control. Statistical analysis conducted using one-way ANOVA with Bonferroni
uron 68, 1128–1142, December 22, 2010 ª2010 Elsevier Inc. 1131
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Figure 2. Homer1a Is an Upstream Regulator of Agonist-Independent Activity of Group I mGluRs
(A and B) Western blot and quantification demonstrating Homer1a or Arc transgene expression reduced surface GluA1 and GluA2. Bay/MPEP blocked the effect
of Homer1a, but not Arc. n = 4; *p < 0.05, **p < 0.01, ***p < 0.001.
(C–F) Immunocytochemistry and quantification demonstrating Homer1a or Arc transgene expression reduced surface expression of GluA1 (C and D) and GluA2
(E and F), and coapplication of Bay/MPEP prevented Homer1a-induced, but not Arc-induced, effects (scale bar represents 30 mm and 5 mm in magnified
dendrites). n = 12–24 each group; ***p < 0.001.
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Figure 3. Synaptic AMPARs Are Elevated in Homer1a KO Neurons
(A and B) Representative immunocytochemistry and quantification of surface-labeled GluA1 and GluA2 on WT and Homer1a KO primary cortical neurons (scale
bar represents 30 mm and 5 mm in magnified dendrites). n = 24 for each group; **p < 0.01.
(C and D)Western blots and quantification showed that surface GluA1, GluA2/3, andmGluR5 were increased on Homer1a KO neurons. n = 8 for each group; *p <
0.05.
(E) Representative whole-cell recording traces fromWT and Homer1a KO neurons. Cumulative probability distribution of mEPSC amplitude or frequency in either
control (n = 24 cells) or Homer1a KO (n = 33 cells). Inset: bar graphs represent the mEPSC mean amplitude or frequency of each population. mEPSC amplitudes
were increased in Homer1a KO neurons (***p < 0.001). No change in frequency was observed.
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Homer1a and Homeostatic Scalinguntreated Homer1a KO neurons. Comparison of Homer1a KO
neurons treated with bicuculline versus TTX suggested a small
difference but was not statistically significant (27.2 ± 1.9 pA
compared to 31.4 ± 2.6 pA; p = 0.19, not significant); this is
dramatically different than WT neurons (14.1 ± 0.2 pA compared
to 30.1 ± 2.2 pA). There was no difference in the frequency of
mEPSCs between TTX-treated WT neurons (24.4 ± 2.6 Hz;
n = 24 cells), bicuculline-treated WT neurons (22.2 ± 1.7 Hz;
n = 28 cells), untreated WT neurons (23.4 ± 2.6 Hz; n = 24 cells),
or similarly treated Homer1a KO neurons (TTX-treated, 24.9 ±
2.6 Hz; n = 20 cells; bicuculline-treated 27.6 ± 2.8 Hz; n = 35 cells;
untreated 25.3 ± 2.9 Hz; n = 33 cells) (Figure 5G). These observa-
tions confirm that homeostatic changes of synaptic strength are
markedly disrupted in Homer1a KO neurons. The modestNechange of surface GluA1 detected in biochemical and IHC
studies of Homer1a KO neurons is not manifest in electrophysi-
ological data perhaps because GluA2 is the predominant
receptor or theGluA1 that is scaled is extrasynaptic. Extrasynap-
tic pools of GluA1 have been described and implicated in
synaptic plasticity (Makino and Malinow, 2009).
Chronic application of Bay and MPEP results in an increase of
surface AMPAR and mEPSCs in WT neurons (Figure 1). If this
increase reflects a block of the action of Homer1a that is
expressed at steady state levels in neuronal cultures, it predicts
that Bay and MPEP should not increase surface AMPAR
in Homer1a KO neurons. This prediction was confirmed in
both biochemical and electrophysiological assays (Figures
S3A–S3D).uron 68, 1128–1142, December 22, 2010 ª2010 Elsevier Inc. 1133
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Figure 4. Homer1a Reduces Elevated Surface AMPARs and mGluR5 on Homer1a KO Neurons
(A–C) Whole cell recordings from Homer1a KO neurons infected with GFP or Homer1a Sindbis virus. Representative traces cumulative probability distribution
of mEPSC amplitude or frequency. Inset: bar graphs represent the mEPSC mean amplitude or frequency of each population. Homer1a-expressing neurons
(n = 10 cells) had significantly reduced mEPSC amplitudes compared to GFP neurons (n = 13) (*p < 0.05). No change in frequency was observed.
(D and E) Western blots and quantification demonstrating Homer1a transgene expression reduced surface expression of glutamate receptors (n = 4 each group;
*p < 0.05) on Homer1a KO neurons.
(F) Homer1a transgene expression reduced mGluR5 co-IP with Homer1c from WT neurons.
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Homer1a and Homeostatic ScalingHomer1a Scaling Does Not Require Arc
To assess how Homer1a downregulates surface AMPAR, we
first considered the possibility that constitutive activation of
group I mGluR would result in ongoing Arc translation. mGluR-
receptor activation results in the rapid de novo translation of
Arc and this is required for mGluR-LTD (Park et al., 2008; Waung
et al., 2008), consistent with Arc’s function to increase the rate of
endocytosis of AMPAR (Chowdhury et al., 2006). However,
Homer1a expressed in Arc KO cortical neurons by Sindbis virus
resulted in downregulation of surface AMPAR identical to
Homer1a’s effect in WT neurons (Figures S4A and S4B). This
observation indicates that the action of Homer1a is not depen-
dent on Arc, and suggests that Homer1a and Arc function by
independent pathways.
Homer1a Reduces GluA2 Tyrosine Phosphorylation
To assess the mechanism of Homer1a-dependent downregula-
tion of surface AMPAR, we screened pharmacological agents
for their ability to prevent effects of Homer1a expression by
Sindbis virus on cortical neurons. Inhibition of tyrosine phospha-
tase by sodium orthovanadate (Na3VO4) prevented Homer1a-
induced downregulation of AMPAR (Figure 6A). GluA2 is1134 Neuron 68, 1128–1142, December 22, 2010 ª2010 Elsevier Incphosphorylated on tyrosines in the C terminus, and reduction
of tyrosine phosphorylation is linked to reduced surface expres-
sion (Ahmadian et al., 2004; Hayashi and Huganir, 2004). To
examine this pathway, GluA2 was immunoprecipitated and
blotted with phospho tyrosine Ab. Homer1a expression reduced
GluA2 tyrosine phosphorylation (Figure 6B). Moreover, the
effect of Homer1a to reduce GluA2 tyrosine phosphorylation
was blocked by treatment of neurons with Bay and MPEP indi-
cating that this action of Homer1a is dependent on group I
mGluR signaling (Figure 6B). To explore the link between
Homer and GluA2 tyrosine phosphorylation in vivo, we assayed
cortex of WT and Homer1a KO mice. GluA2 tyrosine phosphor-
ylation was increased in Homer1a KO cortex (Figure 6C). As
a further test of this model, we examined Homer KO mice
with genetic deletions of Homers 1, 2, and 3 (Homer TKO).
Because these mice lack all Homer proteins, the model of
Homer1a function that suggests it displaces long form Homer
predicts that Homer TKO mice should mimic overexpression
of Homer1a. Consistent with this prediction, tyrosine phosphor-
ylation of GluA2 is markedly reduced (Figure 6D). Moreover,
expression of GluA1 and GluA2/3 on the surface of Homer
TKO cortical neurons in culture is reduced without changes in.
Neuron
Homer1a and Homeostatic Scalingtotal expression of these receptors (Figure 6E). Whole cell
recordings of pyramidal neurons from layer II-III of acute cortical
slices confirmed mEPSC amplitude from Homer TKO is
decreased compared to WT (Figure 6F: Homer TKO 8.2 ±
0.2 pA; 9.7 ± 1.9Hz; n = 11 cells; WT 12.5 ± 1.4 pA; 9.8 ±
1.7Hz; n = 13 cells; **p < 0.01).
The acute effect of tyrosine phosphatase inhibitor Na3VO4
on mEPSC was examined in cortical neurons expressing
Homer1a or GFP transgenes. Na3VO4 application increased
mEPSC amplitude in Homer1a-expressing neurons, but not
GFP-expressing neurons (Figure 6G). As a further test of the
prediction that levels of surface AMPAR are reduced in Homer
TKO mice due to a reduction of tyrosine phosphorylation, we
monitored the mEPSC in acute cortical slices prepared from
Homer TKO mice. Consistent with assays in cultures, addition
of Na3VO4 to the perfusion buffer resulted in an increase of
mEPSC in neurons from Homer TKO mice, but not WT mice
(Figure 6H).
These data support a model in which constitutive group I
mGluR activity, due to interruption of Homer binding, results in
reduced GluA2 tyrosine phosphorylation and a consequent
reduction of synaptic strength. As a further test of this model,
we monitored the effect of acute blockade of group I mGluR
activity, comparingWt and Homer TKO neurons, with the expec-
tation that reduced mEPSCs (Figure 6F) linked to reduced
tyrosine phosphorylation is maintained by constitutive mGluR
activity. Application of Bay (50 mM) and MPEP (10 mM) resulted
in an acute increase of the mEPSC amplitude from neurons
recorded in slices from Homer TKO mice, but not WT mice
(Figure 6I).
Homer 1a Is Not Required for mGluR-LTD
The finding that homeostatic scaling is dependent on mGluR
signaling suggests that homeostatic scaling may share mecha-
nisms with mGluR-LTD. We first asked if mGluR-LTD is depen-
dent on Homer1a using the acute hippocampal slice prepara-
tion. The mGluR5 agonist DHPG evoked robust LTD of the
Schaffer-CA1 synapse that was monitored to 90 min, and was
identical to WTmice (Figure S5A). Thus, Homer1a is not required
for the induction or initial maintenance of mGluR-LTD.
Bicuculline Scaling Occludes Chemical mGluR-LTD
We also examined how homeostatic scaling may impact mGluR-
LTD bymonitoring chemical LTD in cortical cultures after chronic
bicuculline treatment. Acute treatment with DHPG (50 mM)
resulted in robust downregulation of surface AMPAR in WT
cortical neurons; however, DHPG treatment did not reduce
surface AMPAR when added 48 hr after treatment with bicucul-
line (Figure S5B). Thus, bicuculline treatment evokes a downre-
gulation of surface AMPARs that appears to occlude further
reductions by DHPG treatment.
Homer1a Contributes to the Induction of Scaling
The effect of acute application of Bay and MPEP to increase
mEPSC in Homer TKO slices (Figure 6I) suggested this response
may be useful to monitor the action of Homer1a. In WT neurons
expressing Homer1a transgene, acute application of Bay and
MPEP resulted in a gradual increase of mEPSC amplitudeNe(Figures 7A and 7B). This same phenomenon was detected in
WT neurons 20–24 hr after the addition of bicuculline (Figure 7C
and 7D), which parallels the time course of Homer1a protein
induction (Figure 5A). AcuteBay andMPEPdid not altermEPSCs
in WT neurons after 48 hr treatment of bicuculline (Figures S6A
and S6B). These data suggest that Homer1a contributes to the
induction of homeostatic scaling by enhancing mGluR activity,
and thismechanismmakes relatively less contribution tomainte-
nance of scaling. In further support of this model, Bay and
MPEP treatment, which blocks the scaling effect of bicuculline
(Figure 1), does not reverse bicuculline scaling even if applied
for an additional 48 hr after bicuculline (Figures S6C and S6D).
Homer 1a Scaling In Vivo
To examine Homer 1a scaling in vivo, wemonitored responses of
layer II-III pyramidal neurons in the acute cortical slices. As in
culture, Homer1a KO pyramidal neurons had larger amplitude
mEPSCs than WT neurons (Figures S7A and S7B: Homer1a
KO 13.2 ± 0.8 pA; n = 7 cells; WT 10.4 ± 0.7 pA; n = 8 cells;
*p < 0.05). There was no difference in mEPSC frequency
betweenWT (14.9 ± 1.7 Hz; n = 8 cells) andHomer1a KO neurons
(16.7 ± 3.8 Hz; n = 7 cells; Figures S7A and S7B). Acute applica-
tion of Bay (50 mM) and MPEP (10 mM) to slices from naive WT
or Homer1a KO mice did not change the amplitude of mEPSCs
(not shown). To assess the contribution of activity-inducible
Homer1a, we treated WT and Homer1a KO mice with MECS
and prepared cortical slices 2 hr later. Slices were used for
recordings 1–2 hr after preparation to correspond to the point
of maximal expression of Homer1a protein after MECS
(Brakeman et al., 1997). Homer1a mRNA was detected by
in situ hybridization in 13% of layer II-III cortical neurons in
naive mice, and in 35% of neurons in MECS treated mice
(Figures S7C and S7D). Accordingly, we anticipated that effects
of Homer1a might be evident in approximately one-third of
randomly selected neurons. A comparison of mEPSC ampli-
tudes in neurons from naive WT mice versus those treated with
MECS showed a significant decrease in mEPSC amplitudes,
whereas a similar comparison in Homer1a KO mice did not (Fig-
ure S7E). Bath application of Bay andMPEP increased the ampli-
tude of mEPSCs in a subset of WT neurons (4/15) after MECS
(Figures 7E and 7F). By contrast, bath application of Bay and
MPEP did not result in an increase in mEPSC amplitude of
neurons from Homer1a KO mice (0 of 16 neurons; different
from WT neurons p < 0.05 using Fisher’s exact test) (Figures
7E and 7F). To confirm the hypothesis that activity evokes consti-
tutive mGluR signaling that reduces synaptic strength in WT
mice, we employed a fos-GFP reporter mouse to identify living
neurons that were activated by MECS (Barth et al., 2004). C-
fos and Homer1a are coordinately induced in neurons by
MECS (Barnes et al., 1994), and GFP was detected in approxi-
mately one-third of layer II-III pyramidal neurons after MECS.
Bay and MPEP evoked a consistent increase of mEPSC re-
corded from GFP-expressing neurons after MECS (all neurons),
but not from neurons lacking GFP (Figures 7G and 7H). These
data are consistent with studies in neuronal cultures and support
the hypothesis that neural activity in vivo evokes a reduction of
mEPSC amplitude that is dynamically dependent on Homer1a
and acutely reversed by inhibition of group I mGluR.uron 68, 1128–1142, December 22, 2010 ª2010 Elsevier Inc. 1135
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Figure 5. Homeostatic Scaling of AMPARs Is Impaired in Homer1a KO Neurons
(A) Real-time RT-PCR and immunoblot quantitation of Homer1a expression in primary cortical culture after chronic treatment with TTX or bicuculline. Bicuculline-
induced Homer1a mRNA expression peaked 4–8 hr and returned to basal at 48 hr, whereas Homer1a protein peaked at 12 hr. n = 4 each group; *p < 0.05, ***p <
0.001. NS indicates a nonspecific band that reacts with Homer1a Ab.
(B and C) Western blots and quantification of glutamate receptors in WT and Homer1a KO cultured cortical neurons treated 48 hr with TTX (1 mM) or bicuculline
(40 mM). Homer1a KO neurons underwent less scaling of GluA1 and GluA2/3. n = 8 each group; *p < 0.05, **p < 0.01 versus WT; #p < 0.05, ###p < 0.001 versus
control; n.s., no significance.
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Group I mGluR, Homer1a, and Homeostatic Scaling
of AMPARs
Group I mGluR signaling in neurons encompasses a broad range
of physiological outputs including dynamical control of Ca2+
release from intracellular stores (Feng et al., 2002; Tu et al.,
1998; Yuan et al., 2003), Ca2+ influx via TRPC channels (Yuan
et al., 2003), modulation of VSCC (Kitano et al., 2003), biosyn-
thesis of phosphoinositides and cannabinoids (Maejima et al.,
2001), regulation of protein synthetic pathways and activation
of signaling kinases including ERK and PI3K (Park et al., 2008).
Many of these outputs are coupled by Homer and are differen-
tially altered by Homer1a (Kammermeier, 2008). The present
study demonstrates that group I mGluRs play an essential role
in homeostatic scaling of AMPAR. This represents a new func-
tion for mGluR signaling in neural plasticity, and reinforces the
notion that Hebbian and non-Hebbian forms of plasticity can
utilize shared pathways, albeit in ways that selectively modify
individual synapses or cell-wide properties. mGluR signaling
that mediates Hebbian forms of plasticity such as mGluR-LTD
(Oliet et al., 1997) and spike-timing dependent plasticity (Dan
and Poo, 2004) are driven by synaptically released glutamate
and are localized to discrete regions of the dendrite. mGluR
activity that drives homeostatic scaling is not dependent on
glutamate acting at the receptor because scaling is not blocked
by chronic treatment with competitive or neutral antagonists.
Rather, mGluR activity that mediates scaling appears to be
due to Homer1a disruption of the crosslinking activity of consti-
tutively expressed long-form Homers, and occurs as a cell-wide
response. The unique property of group I mGluR to signal in an
agonist-independent mode that is controlled by an IEG creates
an elegant mechanism to balance Hebbian and non-Hebbian
plasticity.
Both Homer 1a and Arc contribute to homeostatic scaling, but
appear to mediate independent pathways. Thus, Homer1a
scaling is dependent on mGluR activity whereas Arc scaling is
not. Moreover, Homer1a scaling is intact in Arc KO neurons.
In contrast to Arc, which appears to be essential for both
mGluR-LTD and homeostatic scaling, Homer1a appears to be
selectively required for scaling because mGluR-LTD is intact in
Homer1a KO hippocampus. The observation that mGluR
signaling is modulated by an IEG and is essential for both
Hebbian and non-Hebbian plasticity anticipates dynamical inter-
actions between these forms of plasticity that are dependent on
the activity history of the neuron. Our observation that scaling to
chronic bicuculline prevents chemical LTD in cultured neurons
provides an initial demonstration of this point.
The effect of Homer1a-dependent activation of mGluR can be
revealed by acute increases of mEPSCs in response to inverse(D and E) Representative immunohistochemistry and quantification of surfaceGluA
or bicuculline. KO neurons exhibited impaired scaling (scale bar represents 30 mm
#p < 0.05, ##p < 0.01, ###p < 0.001 versus control; n.s., no significance.
(F and G) Representative whole-cell recording traces and cumulative probability
neurons after TTX (WT: n = 15 cells, KO: n = 20 cells) or bicuculline (WT: n = 28 cel
mean amplitude or frequency of each population. Although WT neurons showed
significant changes of mEPSC amplitudes or frequency. ***p < 0.001 versus no
Bonferroni correction, scale = 60 pA, 0.1 s.
Neagonists. This effect is time-dependent and parallels the dynam-
ical expression of Homer1a. Together with the observation
that blockade of mGluR cannot reverse bicuculline-induced
scaling once it is established suggest that Homer1a/mGluR are
involved in the induction, but not the maintenance, of scaling.
Although other mechanisms may contribute to agonist-indepen-
dent signaling of group I mGluRs, such as phosphorylation
dependent interruption of Homer multimerization (Brock et al.,
2007; Mizutani et al., 2008), the phenotypic similarity of Homer1a
KO neurons to WT neurons treated with group I mGluR inverse
agonists suggests that Homer1a is the predominant regulator
of agonist-independent signaling during homeostatic scaling.
HomerRegulates theTyrosine Phosphorylation ofGluA2
Examination of the mechanism of Homer1a-dependent scaling
revealed a role for Homer as a regulator of the tyrosine phos-
phorylation of GluA2. This effect is manifest after acute increases
of Homer1a and is evident in vivo in both Homer1a KO and
Homer TKO mice. The scaling effect of Homer1a transgene
expression in cultured neurons is dependent on mGluR activity
and all data are consistent with a canonical function of Homer1a.
Thus, manipulations that interrupt Homer crosslinking, including
Homer1a expression or deletion of all crosslinking forms of
Homer (Homer TKO) result in reduced tyrosine phosphorylation
of GluA2, whereas selective KO of Homer1a results in increased
tyrosine phosphorylation. Inhibition of tyrosine phosphatase,
which increases GluA2 tyrosine phosphorylation, prevents
Homer1a-dependent downregulation of surface GluA2 and
results in acute increases of synaptic strength in acute cortical
slices of Homer TKO mice. Similar effects of tyrosine phospha-
tase inhibitors were noted on evoked synaptic responses in
acute hippocampal slices (unpublished observation). GluA2 traf-
ficking is linked to its tyrosine phosphorylation (Ahmadian et al.,
2004; Hayashi and Huganir, 2004), and mGluR-LTD has been
linked to de novo translation of the tyrosine phosphatase STEP
(Zhang et al., 2008). The molecular basis of regulated tyrosine
phosphorylation of GluA2 in scaling remains to be explored.
Homer 1a and Homeostatic Changes in Surface mGluR5
Surface expression of mGluR5 is increased by chronic treatment
with TTX and reduced by chronic treatment with bicuculline, in
a manner that parallels homeostatic changes in AMPAR (Fig-
ure 5). Homer1a may play a role in this process because surface
mGluR5 is increased on Homer1a KO neurons, and Homer1a
transgene expression downregulates surface mGluR5 (Figure 4).
These effects contrast with previous studies in which Homer1a
transgene expression increased surface mGluR5 (Ango et al.,
2002). Differences in the duration of Homer1a expression may
underlie this disparity. Importantly, scaling of surface mGluR5
is not significantly different in Homer1a KO neurons compared1 andGluA2 inWT andHomer1a KO cortical neurons treated for 48 hr with TTX
and 5 mm inmagnified dendrites). n = 11–24; *p < 0.05, ***p < 0.001 versusWT;
distributions of mEPSC amplitude and frequency from WT and Homer1a KO
ls, KO: n = 35 cells) treatment for 48 hr. Inset: bar graphs represent the mEPSC
the expected scaling of mEPSC amplitudes, Homer1a KO neurons showed no
treatment control. Statistical analysis conducted using one-way ANOVA with
uron 68, 1128–1142, December 22, 2010 ª2010 Elsevier Inc. 1137
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Figure 6. Homer1a Reduces GluA2 Tyrosine Phosphorylation
(A) Western blots and quantification show that sodiumorthovanadate (1mM,Na3VO4) blocks the scaling effect of Homer1a [Sindbis virus (24 hr)] onGluA2/3. n = 5
each group; *p < 0.05 versus GFP control.
(B) Homer1a reduces GluA2 tyrosine phosphorylation, and is blocked by Bay/MPEP. n = 4–5 each group; *p < 0.05 versus GFP control.
(C) GluA2 tyrosine phosphorylation is elevated in the brain of Homer1a KO mice compared to WT mice. n = 4 each group; *p < 0.05 versus WT.
(D) GluA2 tyrosine phosphorylation is reduced in the brain of Homer TKO mice compared to WT mice. n = 4–5 each group; *p < 0.05 versus WT.
(E) Surface GluA1 and GluA2/3 are decreased in Homer TKO cortical neurons. n = 6 for each group, **p < 0.01.
(F) Cumulative probability distribution of mEPSC amplitude and frequency from pyramidal neurons of layer II-III prefrontal cortex in slices prepared from naiveWT or
HomerTKOmice. Inset:bargraphs represent themEPSCmeanamplitudeor frequency.HomerTKOneuronshadsignificantlysmallermEPSCamplitudes (**p<0.01).
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Figure 7. Homer1a Scaling of Synaptic
AMPARs Is Acutely Reversed by mGluR
Inverse Agonists
(A and B) Representative traces and the popula-
tion time course of mEPCS recorded from WT
cultured cortical neurons infected with Homer1a
Sindbis virus for 8–15 hr (bin = 10 s, n = 11 cells).
Acute bath application of Bay/MPEP increased
mEPSC amplitude (***p < 0.001).
(C and D) WT cultured cortical neurons (n = 7 cells)
were incubated for 20–24 hr with Bic. Acute bath
application of Bay/MPEP increased mEPSC
amplitude (***p < 0.001).
(E and F) Representative whole-cell recording
traces frommice that received a single electrocon-
vulsive seizure (MECS) 2 hr before slice prepara-
tion and were subsequently recorded within 2 hr.
Bay/MPEP increased the amplitude of mEPSCs
in a subset of WT neurons (n = 4 of 15 cells), but
not in Homer 1a KO neurons (n = 0 of 16 cells;
p < 0.05 using Fisher’s exact test) (scale = 60 pA,
0.1 s, bin = 10 s).
(G and H) Representative traces and the popula-
tion time course of mEPSC recorded from Fos-
GFP mice that received a single electroconvulsive
seizure (MECS) 2 hr before slice preparation and
were subsequently recorded within 2 hr. Bay/
MPEP increased the amplitude of mEPSCs in all
GFP-expressing neurons (n = 7 cells), but not in
neurons that did not express GFP (no GFP)
(n = 5 cells; *p < 0.05).
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Homer1a and Homeostatic Scalingto WT neurons, despite the marked reduction of homeostatic
changes in AMPAR. This suggests that mechanisms other
than Homer1a regulate surface mGluR expression during
homeostatic scaling, and that changes in surface expression of(G) Representative traces and the population time course of mEPCS recorded fromWT cultured cortical neuro
or GFP Sindbis virus (n = 8 cells) for 8–15 hr (bin = 10 s). Acute bath application of Na3VO4 (1 mM) increase
(H and I) Representative traces and population time course of mEPCS recorded from WT pyramidal neuron
from naive WT or Homer TKO mice. Acute bath application of Na3VO4 (1 mM) or Bay/MPEP increase
(*p < 0.05, ***p < 0.001).
Neuron 68, 1128–1142, DemGluR5 are not critical for AMPAR traf-
ficking. mGluR5 endocytosis has been
reported to occur by both activity-depen-
dent and activity-independent pathways
(Dhami and Ferguson, 2006). Mecha-
nisms that control mGluR trafficking in
homeostatic scaling and the physiolog-
ical significance remain to be determined.
mGluR-Dependent Scaling and
Implications for Disease
Group I mGluRs are implicated in several
diseases of cognition. For example,
mGluR5 signaling is increased in mouse
models of fragile X mental retardation
syndrome (Huber et al., 2002) and may
be relevant in developing therapies
(Bear, 2005). Group I mGluR are consid-ered important targets for treatment of depression, schizo-
phrenia, and Alzheimer disease (Conn et al., 2009). Drug addic-
tion is also dependent on mGluR5 signaling as mGluR5 KOmice
show a reduced behavioral response to cocaine (Chiamulerans infected with Homer1a Sindbis virus (n = 9 cells)
s mEPSC amplitude (**p < 0.01).
s of layer II-III prefrontal cortex in slices prepared
d mEPSC amplitude increase mEPSC amplitude
cember 22, 2010 ª2010 Elsevier Inc. 1139
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Homer1a and Homeostatic Scalinget al., 2001) and mGluR5 inverse agonists prevent self adminis-
tration in monkeys (Lee et al., 2005). The present study focuses
attention on the possible role of homeostatic scaling in the path-
ogenesis of these disorders, and identifies an important physi-
ology to consider in the chronic use of mGluR pharmaceuticals.
EXPERIMENTAL PROCEDURES
Antibodies and Chemicals
The following antibodies were previously described or obtained commercially:
mGluR1 (mouse monoclonal) from BD Biosciences; mGluR5 from Upstate;
N-GluA2 from Chemicon; horse radish peroxidase (HRP) conjugated HA anti-
body, HRP-conjugated myc antibody, myc (mouse monoclonal) from Santa
Cruz; actin (mousemonoclonal) fromSigma Aldrich. GluA2CPYwas described
previously (Hayashi and Huganir, 2004). Homer1, Homer2, and Homer3 were
generated and described before.
The following drugs andchemicalswere purchased fromTocris Biosciences:
tetrodotoxin, bicuculline, Bay 36-7620, MPEP, LY367385, and (S)-MCPG,
CPCCOEt.
Generation of Homer1a-Specific Knockout Mice
The Homer1a targeting construct was generated by fusing 2.7 kb of genomic
DNA, including intron 4 (part thereof) and exon 5 of the Homer1 gene, with
part of the rat Homer1c cDNA (2 kb), containing exons 6–10, the hGH
polyadenylation site and a ‘‘floxed’’ Pgk-neo cassette, followed by 7.2 kb of
Homer1 gene sequence. The linearized (NotI, KpnI) targeting construct was
electroporated into ES ([129X1/SvJ 3 129S1] F1) cells. G418 resistant ES
cell clones were screened by PCR and Southern blotting for homologous
recombination. Correctly targeted ES cells were injected into blastocysts,
and chimeras were mated with C57BL/6 mice to produce heterozygous
Homer1a knockouts.
Neuronal Culture
Neuronal cortical cultures from embryonic day 18 (E18) pups were prepared as
reported previously (Rumbaugh et al., 2003), with minor alterations. For
biochemistry experiments, 1 3 106 neurons were added to each well of a
6-well plate (Corning) coated with poly-L-lysine. For recording experiments,
2 3 106 neurons were added to each 60 mm dish (Corning) with coverslips
coated with poly-L-lysine. Growth medium consisted of NeuroBasal
(Invitrogen) supplemented with 1% fetal bovine serum (Hyclone), 2% B27,
1% Glutamax (Invitrogen), 100U/mL penicillin, and 100U/mL streptomycin
(Invitrogen). Neurons were fed twice per week with glia conditioned growth
medium.
Immunocytochemistry, Microscopy, and Data Analysis
Surface staining was described previously (Shepherd et al., 2006). Briefly, to
label surface GluA1-containing AMPA receptors, 2.5 mg of GluA1-N
JH1816 pAb was added to neuronal growth media and incubated at 10C
for 20 min. To label surface GluA2-containing AMPA receptors, 1 mg of
GluA2-N Ab was added to neuronal growth media and incubated at 37C for
15 min. The unbound excess antibody was quickly washed with fresh warmed
growth medium and then fixed in 4% paraformaldehyde, 4% sucrose contain-
ing PBS solution for 20 min at 4C. Neurons were subsequently exposed to
Alexa 555 secondary antibody (1:500; Molecular Probes) and incubated at
room temperature for 1 hr. After that, neurons were permeabilized with 0.2%
Triton X-100 in PBS for 10 min. Coverslips were mounted on precleaned slides
with PermaFluor and DABCO.
Immunofluorescence was viewed and captured using a Zeiss LSM 510
confocal laser scanning microscope using the same settings. Quantification
of surface GluA1 or GluA2 puncta were carried out essentially as described
(Rumbaugh et al., 2003), using Metamorph imaging software (Universal
Imaging). Images were acquired and saved as multichannel TIFF files with
a dynamic range of 4096 gray levels (12-bit binary; MultiTrack acquisition for
confocal). To measure punctate structures, neurons were thresholded
by gray value at a level close to 50% of the dynamic range. Background
noise from these images was negligible. After a dendrite segment was1140 Neuron 68, 1128–1142, December 22, 2010 ª2010 Elsevier Incselected, all puncta were treated as individual objects and the characteristics
of each, such as pixel area, average fluorescence intensity, and total fluores-
cence intensity, were logged to a spreadsheet. In addition, each dendrite
length was logged to calculate puncta density and total intensity per dendritic
length. The average pixel intensity from each region was calculated using
total intensity dividing by dendritic length and averages from all regions were
derived. The average pixel intensity in each group was normalized to their
control group. Significance was determined by a Student’s t test.
Surface Biotinylation Assay
For surface biotinylation, drug-treated cortical neurons were cooled on ice,
washed twice with ice-cold PBS++ (13 PBS, 1 mM CaCl2, 0.5 mM MgCl2)
and then incubated with PBS++ containing 1 mg/ml Sulfo-NHS-SSBiotin
(Pierce) for 30 min at 4C. Unreacted biotin was quenched by washing cells
three times with PBS++ containing 100 mM Glycine (pH 7.4) (briefly once
and for 5 min twice). Cultures were harvested in RIPA buffer and sonicated.
Homogenates were centrifuged at 132,000 rpm for 20 min at 4C. Fifteen
percent of supernatant was saved as the total protein. The remaining 85%
of the homogenate was rotated with Streptavidin beads (Pierce) for 2 hr.
Precipitates were washed with RIPA buffer three times (5 min each time). All
procedures were done at 4C.
Slice Preparation
ECS was induced through a constant-current generator (ECT unit; Ugo Basile,
Comerio, Italy) (Cole et al., 1990), in accordance with the guidelines of the
Johns Hopkins Animal Care and Use Committee. The brain was dissected
2 hr after ECS and placed immediately into cold (2.5C) modified CSF
composed of the following (in mM): 110 choline chloride, 2.5 KCl, 7 MgCl2,
0.5 CaCl2, 2.4 Na-pyruvate, 1.3 Na-ascorbic acid, 1.2 NaH2PO4, 25 NaHCO3,
and 20 glucose. Coronal brain slices of the prefrontal cortex (250 mm) were
prepared from P20-22 WT and Homer1a KO mice using a Vibratome 3000
(Leica Biosystems, St. Louis LLC, St. Louis, MO). After cutting, slices were
incubated for 15 min at 32C and then for up to 3 hr at 25C in ACSF.
Electrophysiology
Whole-cell patch-clamp recordings from cortical cultures and slices were
carried out at 30C–32C. Pyramidal neurons in cortical cultures and the
layer II-III region of the prefrontal cortex were visually identified using Dodt
Gradient Contrast. Transfected neurons were also visually identified under
epifluorescence. The recording chamber was continuously perfused with arti-
ficial cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl, 2.5 KCl,
1.3 MgCl2, 2.5 CaCl2, 1 NaH2PO4, 26.2 NaHCO3, and 10 glucose, equilibrated
with 95% O2 and 5% CO2 (pH 7.4, 305 ± 5 mmol/kg). The bath solution
also contained both 1 mM TTX and 10 mM GABAzine to block action potential
dependent EPSCs and GABAA receptors, respectively. The pipette solution
contained (in mM): 90 Cs-methansulfonate, 48.5 CsCl, 5 ethylene glycol
tetraacetic acid, 2 MgCl2, 2 Na-ATP, 0.4 Na-GTP, and 5 HEPES (pH 7.2,
290 ± 2 mmol/kg). Patch pipettes were pulled from borosilicate glass
(4–5 MU) using a horizontal puller (Sutter Instruments, Novato, CA). Signals
were recorded with a Multiclamp 700B (Molecular Devices, Union City, CA)
amplifier, filtered at 2 kHz and sampled at 10 kHz. To detect a sufficient
number of events (200 events per neuron), recordings were performed on
gap free mode (sweeps of 30 s without any latency). Data were acquired
3 min after achieving the whole-cell configuration. Series resistances (Rs)
of recordings ranged between 10 and 15 MU. Cells were rejected from
analysis if Rs changed by more than 15%. mEPSCs were analyzed by
Mini Analysis Software (Synaptosoft, NJ). All group data are shown as
mean ± standard error of the mean (SEM). Statistical comparison was
performed by the independent t test, ANOVA for multiple comparison (see
Figures 1F and 5G), or Fisher’s exact test (see Figure 7F). All drugs were
purchased from Tocris (Ellisville, MO) except for TTX (Ascent Scientific LLC,
Princeton, NJ).
Statistical Analysis
All the data were analyzed by two-tailed Student’s t test except the analysis of
the multiple comparisons (Figures 1F and 5G). Error bars indicate the SEM..
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